PetIQ

PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. It operates through the Products and Services segments. The Products segment produces and distributes pet medication and health and wellness products to the retail channel. The Services segment represents all veterinary services, and related product sales provided by the firm directly to consumers. Its brands include Advecta, Betsy Farms, Delightibles, Tex Ranch, Mimis Market, and PetLock. The company was founded by McCord Christensen in 2010 and is headquartered in Eagle, ID.

Earnings data Q3 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PetIQ (PETQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

PetIQ (PETQ) Moves 5.7% Higher: Will This Strength Last?

PetIQ is on track to earn record-breaking revenues and FCF due to successful execution and strategic partnerships. The company's success is driven by its diversified product offering and is clearly capitalizing on previous investments - both on Capex and M&A. Scaling and competition pose risks, but there is still significant growth potential, and PETQ stock offers over 100% upside.

PetIQ: Well-Positioned To Grow And Capitalize On The Pet Economy

PetIQ (PETQ) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.51 per share a year ago.

PetIQ (PETQ) Q2 Earnings and Revenues Top Estimates

Record Second Quarter 2023 Net Sales Increase 25% to $314.5 Million  Net Sales and Adjusted EBITDA Exceeds Company's Second Quarter 2023 Guidance  Record Second Quarter Cash from Operations of $57.7 Million  Raises 2023 Annual Outlook

PetIQ, Inc. Reports Second Quarter 2023 Financial Results

EAGLE, Idaho, July 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the second quarter ended June 30, 2023, on Tuesday, August 8, 2023, after the market close.

PetIQ, Inc. to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

Today, we take a look at PetIQ, Inc., which markets both products and services to the growing pet retail sector. The company posted solid quarterly results in May and is growing revenues in the mid to high single digits. An investment analysis follows in the paragraphs below.

PetIQ: Steady Growth Play

PetIQ, Inc. has seen strong growth since its public offering, even as realistic margins are lackluster. The company is essentially largely breaking even for years now, as realistic earnings are badly needed given leverage being apparent on the balance sheet. Shares look cheap, but are only cheap and safe if real margins can be delivered upon, which requires real execution.

PetIQ: Looking Smarter, If Margins Return

EAGLE, Idaho, June 01, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced members of the management team will participate in two upcoming June investor conferences.

PetIQ, Inc. to Participate in Two Upcoming June Investor Conferences

PetIQ (PETQ) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.62 per share a year ago.

PetIQ (PETQ) Tops Q1 Earnings and Revenue Estimates

EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close.

PetIQ, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023

PetIQ is a company operating in a very large market, the pet care and health industry; a market that will see little in the way of slowing down. The earnings came in according to estimates and production was up too, but in the short term, there might be headwinds as inflation bites down on consumer spending.

PetIQ Is A Bet On Steady Trends

PetIQ, Inc. (NASDAQ:PETQ ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Katie Turner - Investor Relations McCord Christensen - Chairman & Chief Executive Officer Zvi Glasman - Chief Financial Officer Michael Smith - President & Chief Operating Officer Conference Call Participants Bill Chappell - Truist Securities Corey Grady - Jefferies Rupesh Parikh - Oppenheimer Jon Andersen - William Blair Elliot Wilbur - Raymond James John Lawrence - Benchmark Operator Good day, and welcome to the PetIQ, Inc. Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.

PetIQ, Inc. (PETQ) Q4 2022 Earnings Call Transcript

PetIQ (PETQ) delivered earnings and revenue surprises of 37.50% and 4.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

PetIQ (PETQ) Reports Q4 Loss, Misses Revenue Estimates

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook

PetIQ, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate PetIQ (PETQ) to Report a Decline in Earnings: What to Look Out for

EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close.

PetIQ, Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 28, 2023

Boston Scientific

PETQ vs. BSX: Which Stock Is the Better Value Option?

PETQ or BSX: Which Is the Better Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing PetIQ (PETQ) Right Now?

Robust financial results from the previous quarter, driven by end-market demand and e-commerce sales channels. Fundamental momentum gathering with profitability a standout last period from strong sales growth.

PetIQ: Re-Rating To Upside, Asymmetrical Risk/Reward

Should Value Investors Buy PetIQ (PETQ) Stock?

The mean of analysts' price targets for PetIQ (PETQ) points to a 100.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Can PetIQ (PETQ) Climb 101% to Reach the Level Wall Street Analysts Expect?

CHICAGO--( BUSINESS WIRE )--Simple Mills, the company on a mission to advance the holistic health of the planet and its people through delicious, better-for-you foods, today announced the addition of CPG industry veteran, Sheryl O'Loughlin, to its Board of Directors. O'Loughlin is an accomplished entrepreneur, CEO, author, and board member bringing extensive experience leading fast-growing, innovative consumer products companies. In her new role, O'Loughlin will provide strategic counsel and guidance to help support Simple Mills in scaling the company to the next level, creating opportunity for the brand to have a greater positive impact on its mission to advance the holistic health of the planet and its people.

Simple Mills Appoints Sheryl O'Loughlin to Board of Directors

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, PetIQ (PETQ) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

PetIQ (PETQ) Shows Fast-paced Momentum But Is Still a Bargain Stock

The average of price targets set by Wall Street analysts indicates a potential upside of 108.3% in PetIQ (PETQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

News for PetIQ Stock (PETQ)